Vivos Therapeutics, Inc. (VVOS)
Largest Insider Buys in Sector
VVOS Stock Price History Chart
VVOS Stock Performance
About Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to …
Insider Activity of Vivos Therapeutics, Inc.
Over the last 12 months, insiders at Vivos Therapeutics, Inc. have bought $0 and sold $0 worth of Vivos Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Vivos Therapeutics, Inc. have bought $42,959 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 14,000 shares for transaction amount of $7,420 was made by Huntsman Ronald Kirk (Chief Executive Officer) on 2023‑06‑20.
List of Insider Buy and Sell Transactions, Vivos Therapeutics, Inc.
| 2023-06-20 | Chief Executive Officer | 14,000 0.059% | $0.53 | $7,420 | -59.28% | |||
| 2023-06-16 | Chief Executive Officer | 15,000 0.065% | $0.54 | $8,050 | -59.28% | |||
| 2023-06-15 | Chief Executive Officer | 21 <0.0001% | $0.50 | $11 | -59.28% | |||
| 2023-06-14 | Chief Executive Officer | 10,000 0.0415% | $0.49 | $4,900 | -59.28% | |||
| 2022-12-23 | Chief Executive Officer | 20,000 0.0911% | $0.50 | $10,000 | -26.62% | |||
| 2022-05-31 | Chief Executive Officer | 8,000 0.0377% | $2.03 | $16,240 | -64.04% | |||
| 2021-09-21 | Chief Executive Officer | 5,000 0.0241% | $4.31 | $21,550 | -50.23% | |||
| 2021-08-17 | Chief Executive Officer | 5,000 0.0214% | $3.00 | $15,000 | -26.00% | |||
| 2021-05-25 | Chief Executive Officer | 4,000 0.0198% | $5.38 | $21,520 | -43.81% | |||
| 2021-05-25 | Chief Financial Officer | 1,000 0.0049% | $5.29 | $5,290 | -43.81% | |||
| 2020-12-24 | Chief Financial Officer | 1,000 0.0078% | $7.38 | $7,380 | -29.54% | |||
| 2020-12-23 | Chief Executive Officer | 1,000 0.0078% | $7.27 | $7,267 | -27.97% | |||
| 2020-12-11 | Chief Executive Officer | 500 0.0037% | $8.50 | $4,250 | -40.16% |
Insider Historical Profitability
| Huntsman Ronald Kirk | Chief Executive Officer | 86521 2.5436% | $3.06 | 11 | 0 | <0.0001% |
| Amman Bradford K. | Chief Financial Officer | 2000 0.0588% | $3.06 | 2 | 0 | <0.0001% |